Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.

Alf KastbomKristina ForslindSofia ErnestamPierre GeborekJohan Karlsson WallmanIngemar F PeterssonSaedis SaevarsdottirLars KlareskogRonald F van VollenhovenKarin Lundberg

Published in: Annals of the rheumatic diseases (2014)

WHO database at the Karolinska institute: CT20080004; and clinicaltrials.gov: NCT00764725.

Keyphrases

rheumatoid arthritis
computed tomography
study protocol
image quality
phase iii
disease activity
dual energy
clinical trial
contrast enhanced
phase ii
interstitial lung disease
positron emission tomography
ankylosing spondylitis
adverse drug
randomized controlled trial
emergency department